1995
DOI: 10.1001/archderm.131.7.829
|View full text |Cite
|
Sign up to set email alerts
|

Superantigens. Do they have a role in skin diseases?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

1995
1995
2008
2008

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 29 publications
0
18
0
Order By: Relevance
“…There have been a number of cases of PRP associated with infection 13,14 including HIV. 15,16 Therefore, a topical compound, such as imiquimod, that promotes an antiviral cytokine profile could conceivably result in the exacerbation of PRP. Furthermore, although the cytokine profile for PRP is still unknown, imiquimod increases the levels of TNF-α , whose inhibition has led to successful treatment of PRP.…”
Section: Prp Exacerbation With Imiquimod Pharmacology and Therapeuticsmentioning
confidence: 99%
“…There have been a number of cases of PRP associated with infection 13,14 including HIV. 15,16 Therefore, a topical compound, such as imiquimod, that promotes an antiviral cytokine profile could conceivably result in the exacerbation of PRP. Furthermore, although the cytokine profile for PRP is still unknown, imiquimod increases the levels of TNF-α , whose inhibition has led to successful treatment of PRP.…”
Section: Prp Exacerbation With Imiquimod Pharmacology and Therapeuticsmentioning
confidence: 99%
“…They bind directly to the major histocompatibility complex class II molecule on the antigen‐presenting cell and stimulate T cells that express certain T‐cell receptors. This leads to polyclonal T‐cell activation with release of immune cytokines such as interleukin‐2, which are important in the pathogenesis of psoriasis 5 . Furthermore, streptococcal superantigens can indirectly induce cutaneous lymphocyte antigen (CLA) on T cells, thereby facilitating their selective migration from dermal capillaries into the dermis 6 .…”
mentioning
confidence: 99%
“…Superantigens activate T-cells through binding to the major histocompatibility complex (MHC) proteins and interacting with the variable portion of the T-cell receptor beta chain (V␤). 3,4 The subsequent release of cytokines such as interleukin-1 and tumor necrosis factor alpha is known to contribute to various conditions in which skin inflammation is a prominent feature, including toxic shock syndrome, mucocutane- ous lymph node syndrome, psoriasis, and atopic dermatitis. Toxic shock syndrome is primarily mediated by the S. aureus superantigen toxic shock syndrome toxin 1 (TSST1), and affected patients have been found to have a selective expansion of V␤2-positive T-cells.…”
Section: Discussionmentioning
confidence: 99%